Coronary heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ??1.Patients with suspected coronary artery disease (CAD) presenting with chest pain or other thoracic discomfort; ??2.Aged 18 to 75 years;?? ??3.Patients and their legal representatives comprehend and cooperate with the intervention strategy of the collaborative framework for PTP assessment of patients with suspected CAD, and provide written informed consent.?
Exclusion criteria
Exclusion criteria: ??1. History of coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), occluder implantation, prosthetic valve replacement, or permanent pacemaker implantation; ??2. Heart failure patients with New York Heart Association (NYHA) functional class III-IV;?? ??3. Prior history of myocardial infarction or myocarditis;? ??4. Hemodynamic or clinical instability, including systolic blood pressure <90 mmHg, severe arrhythmias, valvulopathy, cardiomyopathy, or intracardiac thrombus;?? ??5. Refusal or inability to provide informed consent by patients or legal representatives;?? ??6. Life expectancy <12 months due to significant non-cardiac comorbidities;?? ??7. Congenital heart disease or inherited cardiac disorders;?? ??8. Planned use of pacemakers or vasodilating agents;?? ??9. Concurrent participation in another interventional clinical trial with unevaluated primary endpoints.?
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic Performance;Information Extraction Efficacy;Operation Efficiency; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical Utility;Model Robustness;Human-AI Synergy Quality; | — |
Countries
China
Contacts
Chinese PLA General Hospital